Literature DB >> 25912602

Inflammatory bowel disease and risk of coronary heart disease.

Christine Rungoe1, Nynne Nyboe Andersen2, Tine Jess2.   

Abstract

Emerging data have shown consistent evidence of an association between inflammation and development of atherosclerosis. Systemic autoimmune diseases are characterized by chronic inflammation and immune dysregulation, and diseases such as rheumatoid arthritis and lupus erythematosus are now commonly accepted to associate with development of cardiovascular disease, including coronary artery disease. However, the risk of cardiovascular disease in inflammatory bowel disease (IBD), a chronic inflammatory disease of the gut, is still unclear and the magnitude of a potentially increased risk is continuously debated. The aim of this review is to give an update on the existing literature on the association between inflammatory bowel disease and risk of cardiovascular disease, in particular coronary artery disease, and further to discuss traditional and non-traditional risk factors in patients with inflammatory bowel disease.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25912602     DOI: 10.1016/j.tcm.2015.03.010

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  16 in total

1.  Hospitalizations for Acute Myocardial Infarction Are Decreased Among Patients with Inflammatory Bowel Disease Using a Nationwide Inpatient Database.

Authors:  Edward L Barnes; Renee M Beery; Allison R Schulman; Ellen P McCarthy; Joshua R Korzenik; Rachel W Winter
Journal:  Inflamm Bowel Dis       Date:  2016-09       Impact factor: 5.325

2.  Baicalin alleviates TNBS-induced colitis by inhibiting PI3K/AKT pathway activation.

Authors:  Lei Zhu; Hong Shen; Pei-Qing Gu; Ya-Jun Liu; Lu Zhang; Jia-Fei Cheng
Journal:  Exp Ther Med       Date:  2020-05-06       Impact factor: 2.447

3.  Evaluation of Early Atherosclerosis Markers in Patients with Inflammatory Bowel Disease.

Authors:  Yusuf Üstün; Serta Kilincalp; Şahin Çoban; Yusuf Coşkun; İlhami Yüksel; Aydan Ongun; İrfan Soykan; Mehmet Bektaş; Murat Törüner; Hülya Çetinkaya; Necati Örmeci
Journal:  Med Sci Monit       Date:  2016-10-24

4.  Heart Rate Recovery Is Impaired in Patients with Inflammatory Bowel Diseases.

Authors:  Bahadir Sarli; Yasemin Dogan; Orhan Poyrazoglu; Ahmet Oguz Baktir; Abdullah Eyvaz; Engin Altinkaya; Ahmet Tok; Engin Donudurmaci; Mehmet Ugurlu; Adile Ortakoyluoglu; Hayrettin Saglam; Huseyin Arinc
Journal:  Med Princ Pract       Date:  2016-05-10       Impact factor: 1.927

5.  Risk of cardiovascular disease in inflammatory bowel disease.

Authors:  Ping Wu; Fangyuan Jia; Bao Zhang; Peiying Zhang
Journal:  Exp Ther Med       Date:  2016-12-12       Impact factor: 2.447

Review 6.  Janus Kinase inhibitors in the New Treatment Paradigms of Inflammatory Bowel Disease.

Authors:  Britta Siegmund
Journal:  J Crohns Colitis       Date:  2020-08-01       Impact factor: 9.071

Review 7.  Cardiovascular Manifestations of Inflammatory Bowel Disease: Pathogenesis, Diagnosis, and Preventive Strategies.

Authors:  Diana-Maria Bunu; Cristian-Eugen Timofte; Manuela Ciocoiu; Mariana Floria; Claudia-Cristina Tarniceriu; Oana-Bogdana Barboi; Daniela-Maria Tanase
Journal:  Gastroenterol Res Pract       Date:  2019-01-13       Impact factor: 2.260

8.  Long-term risk of cardiovascular and cerebrovascular disease after removal of the colonic microbiota by colectomy: a cohort study based on the Danish National Patient Register from 1996 to 2014.

Authors:  Anders Boeck Jensen; Teresa Adeltoft Ajslev; Søren Brunak; Thorkild I A Sørensen
Journal:  BMJ Open       Date:  2015-12-15       Impact factor: 2.692

Review 9.  Inflammatory Bowel Disease and Risk of Ischemic Heart Disease: An Updated Meta-Analysis of Cohort Studies.

Authors:  Wan Feng; Guangxia Chen; Dawei Cai; Song Zhao; Jiafei Cheng; Hong Shen
Journal:  J Am Heart Assoc       Date:  2017-08-02       Impact factor: 5.501

10.  Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib-Implications for Cardiovascular Risk and Patient Management.

Authors:  Bruce E Sands; Jean-Frédéric Colombel; Christina Ha; Michel Farnier; Alessandro Armuzzi; Daniel Quirk; Gary S Friedman; Kenneth Kwok; Leonardo Salese; Chinyu Su; Pam R Taub
Journal:  Inflamm Bowel Dis       Date:  2021-05-17       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.